Mumbai : Sun Pharmaceutical Industries is currently trading at Rs. 465.90, up by 3.20 points or 0.69% from its previous closing of Rs. 462.70 on the BSE. The scrip opened at Rs. 469.90 and has touched a high and low of Rs. 469.90 and Rs. 464.75 respectively. So far 8700 shares were traded on the … Read more
Sun Pharmaceutical Industries’ wholly owned subsidiary — DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG from using DUSA’s confidential and proprietary trade secret information. Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical … Read more